Duration of in vivo antimicrobial activity of antibiotic-impregnated cerebrospinal fluid catheters

Neurosurgery

Volumn 58, Issue 5, 2006, Pages 930-934

  Pattavilakom, Ananthababu ^a   Kotasnas, Despina ^a   Korman, Tony M ^a   Xenos, Chris ^a   Danks, Andrew ^a,b  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Antibiotic medication; Shunt infection; Ventriculoperitoneal shunt

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; RIFAMPICIN;

ADULT; ANTIBIOTIC IMPREGNATED CATHETER; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CATHETER; CEREBROSPINAL FLUID SHUNTING; CLINICAL ARTICLE; CONTROLLED STUDY; EXPLANT; HUMAN; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; INFANT; NEUROSURGERY; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SHUNT INFECTION; STAPHYLOCOCCUS AUREUS;

ADULT; ANTI-BACTERIAL AGENTS; CATHETERS, INDWELLING; CEREBROSPINAL FLUID SHUNTS; CHILD; CHILD, PRESCHOOL; COATED MATERIALS, BIOCOMPATIBLE; HUMANS; INFANT; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

EID: 33646847818     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000210155.65102.E7     Document Type: Article

References (21)

1. Abed WT, Alavijeh MS, Bayston R, Shorvon SD, Patsalos PN: An evaluation of the epileptogenic properties of a rifampicin/clindamycin-impregnated shunt catheter. Br J Neurosurg 8:725-730, 1994.
2. Anwar H, Strap JL, Costerton JW: Establishment of aging biofilms: Possible mechanism of bacterial resistance to antimicrobial therapy. Antimicrob Agents Chemother 36:1347-1351, 1992.
3. Bayston R: Preliminary studies on the impregnation of silastic elastomers with antimicrobial substances. Dev Med Child Neurol Suppl 37:50-54, 1976
4. Bayston R: The antibacterial effects of impregnated silastic and its possible applications in surgery. J Pediatr Surg 12:55-61, 1977.
5. Bayston R, Ashraf W, Bhundia C: Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts. J Antimicrob Chemother 53:778-782, 2004.
6. Bayston R, Grove N, Siegel J, Lawellin D, Barsham S: Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 52:605-609, 1989.
7. Bayston R, Lambert E: Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg 87:247-251, 1997.
8. Chandrasekar PH, Rolston KV, Smith BR, LeFrock JL: Diffusion of ceftriaxone into the cerebrospinal fluid of adults. J Antimicrob Chemother 14:427-430, 1984.
9. Govender ST, Nathoo N, van Dellen JR: Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 99:831-839, 2003.
10. Gray ED, Peters G, Verstegen M, Regelmann WE: Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet 1:365-367, 1984.
11. Hampl J, Schierholz J, Jansen B, Aschoff A: In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections. Acta Neurochir (Wien) 133:147-152, 1995.
12. Hampl JA, Weitzel A, Bonk C, Kohnen W, Roesner D, Jansen B: Rifampin-impregnated silicone catheters: A potential tool for prevention and treatment of CSF shunt infections. Infection 31:109-111, 2003.
13. Johnson GM, Lee DA, Regelmann WE, Gray ED, Peters G, Quie PG: Interference with granulocyte function by Staphylococcus epidermidis slime. Infect Immun 54:13-20, 1986.
14. Kanev PM, Sheehan JM: Reflections on shunt infection. Pediatr Neurosurg 39:285-290, 2003.
15. Kockro RA, Hampl JA, Jansen B, Peters G, Scheihing M, Giacomelli R, Kunze S, Aschoff A: Use of scanning electron microscopy to investigate the prophylactic efficacy of rifampin-impregnated CSF shunt catheters. J Med Microbiol 49:441-450, 2000.
16. Latif R, Dajani AS: Ceftriaxone diffusion into cerebrospinal fluid of children, with meningitis. Antimicrob Agents Chemother 23:46-48, 1983.
17. McGirt MJ, Leveque JC, Wellons JC III, Villavicencio AT, Hopkins JS, Fuchs HE, George TM: Cerebrospinal fluid shunt survival and etiology of failures: A seven-year institutional experience. Pediatr Neurosurg 36:248-255, 2002
18. McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sexton DJ: Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis 36:858-862, 2003.
19. Nau R, Prange HW, Muth P, Mahr G, Menck S, Kolenda H, Sorgel F: Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges. Antimicrob Agents Chemother 37:1518-1524, 1993.
20. Pople IK, Bayston R, Hayward RD: Infection of cerebrospinal fluid shunts in infants: A study of etiological factors. J Neurosurg 77:29-36, 1992.
21. Shapiro S, Boaz J, Kleiman M, Kalsbeck J, Mealey J: Origin of organisms infecting ventricular shunts. Neurosurgery 22:868-872, 1988.